Claire M. Bewshea
Exeter, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
HLA-DRB1*01:03 in patients with inflammatory bowel disease: a genotype-phenotype association study.
Journal: The lancet. Gastroenterology & hepatology
Published: February 20, 2026
Clinical Utility and Cost-Effectiveness of Pretreatment NUDT15 Pharmacogenetic Testing to Prevent Thiopurine-Induced Myelosuppression: A Genotype-First Reverse Phenotyping Cohort Study Within the UK NIHR Inflammatory Bowel Disease Bioresource.
Journal: Alimentary pharmacology & therapeutics
Published: March 31, 2025
Understanding Anti-TNF Treatment Failure: Pre-Existing Antidrug Antibodies Are Common but Do Not Neutralize Drug Activity In Vitro or Influence Clinical Response to Infliximab or Adalimumab in Patients with Crohn Disease.
Journal: The journal of applied laboratory medicine
Published: March 27, 2025
Antibody Responses to Influenza Vaccination are Diminished in Patients With Inflammatory Bowel Disease on Infliximab or Tofacitinib.
Journal: Journal of Crohn's & colitis
Published: November 09, 2023
Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study.
Journal: The lancet. Gastroenterology & hepatology
Published: September 26, 2023
Baseline Expression of Immune Gene Modules in Blood is Associated With Primary Response to Anti-TNF Therapy in Crohn's Disease Patients.
Journal: Journal of Crohn's & colitis
Published: June 06, 2023
Anti-TNF Biologicals Enhance the Anti-Inflammatory Properties of IgG N-Glycome in Crohn's Disease.
Journal: Biomolecules
Published: May 11, 2023
Pretreatment Vitamin D Concentrations Do Not Predict Therapeutic Outcome to Anti-TNF Therapies in Biologic-Naïve Patients With Active Luminal Crohn's Disease.
Journal: Crohn's & colitis 360
Published: March 23, 2023
Whole Blood DNA Methylation Changes Are Associated with Anti-TNF Drug Concentration in Patients with Crohn's Disease.
Journal: Journal of Crohn's & colitis
Published: March 14, 2023
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study.
Journal: The lancet. Gastroenterology & hepatology
Published: September 19, 2022
COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study.
Journal: The lancet. Gastroenterology & hepatology
Published: July 23, 2022
Last Updated: 09/26/2026